Financials
- Market Capitalization 43.82 B
- Employee 33 K
- Founded N/A
- CEO Richard Francis
- Website www.tevapharm.com
- Headquarter Israel
- FIGI BBG000C0CD58
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
25.79
Relación precio/flujo de caja
2.1
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 355 | HLN Haleon plc American Depositary Shares | 10.04 USD | -1.47% | +1.21% | +0.20% | +3.29% | 44.94 B USD | ||
| 446 | ZTS Zoetis Inc. Class A Common Stock | 75.01 USD | -3.26% | -0.57% | -3.15% | -48.74% | 31.00 B USD | ||
| 479 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.04 USD | -1.15% | -0.39% | +1.81% | +27.18% | 28.10 B USD | ||
| 613 | VTRS Viatris Inc. - Common Stock | 16.89 USD | +0.24% | +5.50% | -5.96% | +63.19% | 19.40 B USD |